- 1次围观
Burkholderia pseudomallei (B. pseudomallei), strain 1026b was isolated in 1993 from a blood culture of a female rice farmer with diabetes mellitus at Sappasithiprasong hospital in Ubon, Ratchathani, Thailand. The patient was admitted with septicemic melioidosis with soft tissue, skin, joint and splenic involvement, and survived to discharge. B. pseudomallei was isolated from pus and blood samples, strains 1026a and 1026b, respectively, that were obtained 14 days after the onset of symptoms.
B. pseudomallei, strain 1026b was deposited as Multi-Locus Sequence Type (MLST) ST102. Strain 1026b has been tested for antibiotic resistance and is reported to be resistant to streptomycin and sensitive to tetracycline. The genome sequences of chromosomes 1 and 2 of B. pseudomallei, strain 1026b are available (GenBank: NC_017831.1 and NC_017832.1). Genome sequences obtained from strains 1026a and 1026b are reported to be identical. B. pseudomallei, strain 1026b contains a phage, phi1026b, which has been sequenced (GenBank: AY453853). B. pseudomallei, strain 1026b, is also available as BEI Resources NR-4074, which was deposited with an unknown number of additional passages prior to deposition to BEI Resources.
Each vial contains approximately 0.7 mL of
bacterial culture in Tryptic Soy broth supplemented with 10% glycerol. Each vial of Lot 60612106 contains
approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with
10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。